ICICI Prudential Life Insurance lists below issue price

1474191069-577
ICICI Prudential Life Insurance has listed at Rs 330, 1.2% below its issue price of Rs 334 per share, on the National Stock Exchange (NSE).
At 10:01 am, the stock was trading at Rs 331.60, after hitting a high of Rs 333.80 post its listing.
ICICI Prudential Life Insurance has raised Rs 6,057-crore through initial public offer (IPO), become the first insurer to list.
The company's public issue was oversubscribed 10.5 times. The quota set aside for qualified institutional buyers was subscribed 11.83 times while for the non-institutional investor category, it was 28.55 times. The retail portion was oversubscribed 1.42 times, the exchange data shows.
The insurer is a venture between banking major ICICI Bank and UK's Prudential Corporation Holdings. Singapore's Temasek and PremjiInvest are also the shareholders.
At the end of financial year 2016 (FY16), ICICI Prudential was the biggest private sector insurer in the Country having a market share of 11.3%. The company has 521 offices with around 10,663 employees and 121,016 advisors all over India as of FY16. ICICI Prudential Life’s total premium and net profit has risen at a CAGR of 8% and 5% in the past four years, respectively.
Article Source : Business Standard

Comments

Post a Comment

Popular posts from this blog

The Flipkart-ebay deal and the high stake battle with Amazon

Image
Flipkart has been and will continue to make acquisitions to increase scale India's top e-commerce firm   Flipkart   has raised $1.4 billion in its biggest fundraising to date as it takes on US tech giant   Amazon.com   Inc for a larger share of the country's burgeoning online retail market. Chinese social media and entertainment firm Tencent Holdings Ltd, the world's biggest software company Microsoft Corp and online marketplace eBay Inc participated in the funding round, Flipkart said in a statement on Monday, which will value the Indian company at $11.6 billion. That is lower than the $15 billion valuation achieved at its last fundraising in 2015, reflecting how competition has intensified in the e-commerce sector as companies vie for a slice of the world's fastest-growing internet services market. Amazon last year said it would invest over $5 billion in India, and has recently expanded into online video and grocery shopping, seeking to expand aggressively
Read more

Amazon now has customers in 100% serviceable pin-codes in India: Jeff Bezos

Image
If things fall in place, then a deal with a major offline retailer might happen by the end of this year, according to a source Amazon might be the most visited shopping site in India, but for Jeff Bezos, the founder and CEO of the technology giant, it is still Day 1 in what may be the second-most important market for the firm outside the US. Bezos, in a letter to customers, said that Amazon now has customers in 100 per cent serviceable pin-codes in the country and is shipping packages from more than 50 fulfillment locations in 13 states. From talking about how Alexa plays devotional songs in local Indian languages to Amazon India working closely with communities in rural areas, Bezos said that the online marketplace has now become part of the country's culture and has adapted all its services and offerings accordingly. Stressing that Amazon India has captured the top spot for the last two years, Bezos pointed out that Amazon is the most visited site in the cou
Read more

Hypertension drug recall by USFDA shot in the arm for some drug majors

Image
The recall was due to an impurity (N-Nitrosodimethylamine or NDMA) which was found in the recalled products that include valsartan and its combinations   The recent recall of a common  hypertension drug  in the US due to contamination with a carcinogen has opened up short-term opportunities for a handful of Indian players. The issue with sartan (hypertension drug) began around July, when the US Food and Drug Administration (USFDA) notified health care professionals of a voluntary recall of several drug products containing the active ingredient valsartan. Valsartan is used to treat high blood pressure and heart failure. The recall was due to an impurity (N-Nitrosodimethylamine or NDMA) which was found in the recalled products that include valsartan and its combinations. According to the USFDA’s list of products under recall, four companies - Teva, Prinston, Torrent, and Hetero - have recalled products containing the valsartan active ingredient. The USFDA also place
Read more